EU’s Medical Device Regulation, China’s Volume-Based Procurement Program and United Kingdom’s Brexit have significant impacts on the go-to-market strategies of orthopedic companies. Deciding whether it makes sense to introduce new products in these markets — and how to do it effectively — has never been more difficult. This panel of experts touches on the ways that new regulatory requirements and pricing structures are impacting the marketing of orthopedic devices and highlights questions to answer and strategies to implement before launching products in each region.
• Focus on strategic planning to compete in each region and gain market share
• Learn how to optimize current product portfolios and customer targeting
• Understand the more stringent requirements of market entry and how to maximize revenues